Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment.
By J. McEvoy, J. Lieberman, T. Scott Stroup, S. Davis, H. Meltzer, Robert A. Rosenheck, M. Swartz, D. Perkins, R. Keefe, C. E. Davis and 2 more. American Journal of Psychiatry, 2006
963 citations recorded by the source corpus.
Subfields: Psychiatry and Mental health, Philosophy
View Paper: https://www.semanticscholar.org/paper/90bab8b69ec54911f34980d5837b2f6b3480e186
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Psychiatry and Mental health
- Susan M. Shortreed
- Erica E. Moodie
- R. Keefe
- Michael F. Green
- Philip D. Harvey
- Hans-Jürgen Möller
- Eric B. Laber
- Daniel J. Lizotte
In Philosophy
Citations in the corpus
- The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements. (2010, background): “The available empirical evidence continues to support the use of clozapine in people who have not responded to adequate treatment with FGAs.1,2 There is new evidence to suggest that clozapine is more effective than other SGAs in people who have failed to adequately respond to either an FGA or SGA.9,”
- Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. (2007, background): “Patients whose assigned treatment was discontinued could receive other treatments in phases 2 and 3.(64,65) The present report is limited to phase 1 results.”
- World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance (2012, background): “Clozapine was superior to some other SGAs, not including olanzapine, in the CATIE-II and CUtLASS-2 trials (Lewis et al. 2006; McEvoy et al. 2006).”
- Estimating the optimal dynamic antipsychotic treatment regime: Evidence from the sequential multiple assignment randomized CATIE Schizophrenia Study (2012, methodology): “…the design and protocol of the CATIE study have been described in detail elsewhere (Swartz et al., 2003; Stroup et al., 2003, 2006; Lieberman et al., 2005; McEvoy et al., 2006); thus, here we give a brief review of the CATIE study as it pertains to the scientific question of interest of this paper.”